Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05956496 · ClinicalTrials.gov registry record · NA
Gingival Augmentation and Root Coverage With Superficial and Deep Cut Acellular Dermal Matrices
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT05956496: Clinical Trial NA study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT05956496 is a NA study that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05956496, a NA study, was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This entire protocol involves procedures that are standard care and will randomize subjects to of one two routine care procedures. Patients needing root coverage for gingival recession will be enrolled.
Primary Outcome
Measured as change in percentage root coverage
Interventions
- OTHER Allograft Material ADM-S
- OTHER Allograft Material ADM-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-10-03 |
| Est. Completion | 2024-04-09 |
| Phase | NA |
Why NCT05956496 stopped before completion
NCT05956496 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Allograft Material ADM-S is the first listed.
NCT05956496 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05956496 about?
NCT05956496 is a clinical study titled "Gingival Augmentation and Root Coverage With Superficial and Deep Cut Acellular Dermal Matrices". This entire protocol involves procedures that are standard care and will randomize subjects to of one two routine care procedures. Patients needing root coverage for gingival recession will be enrolled.
What is the current status of trial NCT05956496?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2023-10-03. Estimated completion is 2024-04-09.
What interventions are being tested in trial NCT05956496?
The interventions under investigation include: Allograft Material ADM-S (OTHER), Allograft Material ADM-D (OTHER).
Who is sponsoring clinical trial NCT05956496?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05956496's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI